Market Research Blog

The senior in-home care services industry is benefiting from a growing number of aging baby boomers. People now-a days have longer life expectancy due to the advancements in medicine and technology, and thus increasing number of seniors are looking to age in their homes and maintain independence for as long as possible.

Senior in-home care service providers deliver customized solutions according to patient’s budget and needs. Senior in-home care services are provided by licensed healthcare professionals or caregivers and may provide daily assistance to make sure that activities of daily living are met.

Senior in-home care is an alternative to facility care for senior patients who are terminally ill, are recovering from major surgeries or need support for safety at home to prevent unnecessary hospitalization etc. Number of qualified caregivers are increasing over time which is expected to push the adoption of senior in-home care services market over the forecast period of 2017–2027.

The Popularity of in-home health services in the U.S. has increased since in 1995 when more people died of chronic diseases than of acute diseases. Ever increasing need for home-care due to prevalence of chronic diseases itself shows the importance of senior in-home care services.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5525

Senior In-Home Care Services Market: Drivers and Restraints

Rapidly aging population and desire for living independent aging are primary factors driving growth of senior in-home care services market. Average age of the population has risen in last decade and elder people are typically willing to stay at home and maintain existing lifestyle.

According to The Home Care Assistance–one of the providers of senior in-home care services in the U.S. – there will be over 1 Mn centenarians in North America by 2015. Moreover, in-home care services are also getting reimbursement which is expected to enhance the adoption of senior in-home care services in near-term.

Government of many countries are also encouraging people to take in-home care services to minimize healthcare spending. On top of that, rising prevalence of Alzheimer’s disease, Parkinson’s disease and other chronic diseases such as cancer is expected to drive the global market for senior in-home care services over the forecast period of 2017–2027.

However, in developing and underdeveloped countries, in-home care is costlier that the facility care and thus people are not ready to adopt senior in-home care services, which is the major challenge to growth of the global market.

Senior In-Home Care Services Market: Segmentation

Tentatively, global senior in-home care services market has been segmented on the basis of service type, and geography

Based on service type, global senior in-home care services market is segmented as below:

• Wellness and Medical Services
• Companionship Care and Homemaking Services
• Nursing Care Services
• Alzheimer’s and Dementia Care Services
• Hospice Care and Rehabilitation Services
• Physical and Occupational Therapy Services
• Others

Senior In-Home Care Services Market: Overview

The market for senior in-home care services is highly fragmented with no single dominant player in the world as majority of players are operation in particular region or country only. In-home care services are also known as companion aides, personal care aides, certified home health aides or nursing aides. In-home care services to seniors also enrich their lives with physical, metal, social and emotional activities.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-5525

Senior In-Home Care Services Market: Regional Outlook

Geographically, global senior in-home care services market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America clearly dominates the global senior in-home care services market due to high rate of reimbursement for medical as well as non-medical services.

Europe is expected to be the second largest market due to rising number aging of baby boomers requiring care at home. Asia Pacific senior in-home care services market is still in initial phase of development and expected to witness fastest growth in the nearest future due to acceptance for personal dignity of the elder loved ones by the families

Senior In-Home Care Services Market: Key Players

Some of the players identified in global senior in-home care services market include Sunny Days In-Home Care, Inc., Right at Home, LLC., Comfort Keepers Inc., Home Instead Inc. Home Helpers Home Care Services, SYNERGY HomeCare, Home Care Assistance etc. among others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-5525

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Allergy Treatment Market: Drivers and Restraints

Globally, increasing patient population with various type of allergies, changing life style and environment pollution is increasing, which drives the global allergy treatment market. Increasing number of patients with various allergies such as skin allergy, eye allergy, Rhinitis, asthma, etc., changes in dietary habits, rising demand for advanced therapy for allergy treatment, increasing research and development activities, government initiative, are some of the factors that drive the growth of the global allergy treatment market. However, high cost of immunotherapy for allergy treatment and side effects from immunotherapy act as a restraint in the global allergy treatment market.

An allergy is a heightened sensitivity of immune system.  Allergy occurs when a foreign substance which is harmless in nature reacts with immune system. These foreign substances are called allergens. Some of the allergens that affect the immune system are dust mite, animal dander, cockroach, pollens and mold. Dust mite, animal dander and mold can cause indoor allergy problems.

Allergy can be of various types such as eye allergy, Rhinitis, asthma, skin allergy, etc. According to the World Allergy Organization, approximately 30-40% of the world population was affected by allergic condition in 2011. Severe allergy can be life threatening in some patients as allergy severity reduces the function of organs such as allergic asthma causes the poor lungs function.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1342

Allergy Treatment Market: Overview

Allergic diseases occur due to hypersensitivity of the immune system towards environment that usually causes minute problems in most individuals. These allergic diseases includes food allergy, allergic asthma, hay fever, atopic dermatitis and anaphylaxis. Symptoms for these allergic diseases are runny nose, an itchy rash, shortness of breath, red eyes, swelling and some more.

Such allergies are treated by avoiding known allergens, immunotherapy and by the use of medications such as antihistamines and steroids. In industrialized countries, allergic diseases are more common as compared to the countries that are more agricultural or traditional and it is noticed that there is a lower rate of allergic disease in rural populations versus urban populations.

Allergy Treatment Market: Region- wise Outlook

Depending on geographic regions, global allergy treatment market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan and Middle East & Africa. North America followed by Europedominates the global allergy treatment market due to increasing number of patients with various type of allergies including respiratory allergy, skin allergy, eye allergy, etc.

growing environmental pollution, developed healthcare infrastructure and growing demand for immunotherapy for treatment of allergies in these region. Asia-Pacific is the fastest emerging market for global allergy treatment due to growing allergic patient population, increasing awareness about advanced immunotherapy for treatment of allergies available in the market, developing healthcare infrastructure and rising government spending in healthcare industry in this region.

Allergy Treatment Market: Key Players

Some of the key market players in global allergy treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and Vicks.

Currently, the companies which operate in allergy treatment, are entering into mergers and acquisition with other companies to expand its allergy treatment business. For instance, in June 2015, Allergy Therapeutics acquired Alerpharma S.A, a Spanish company develops and now offers allergy immunotherapy products and services to expand its allergy immunotherapy business.

In addition, In November 2015, Pfizer Inc., a multinational pharmaceutical corporation entered into a merger with Allergan PLC, a pharmaceutical company to capture more market share in the drug industry.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1342

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-1342

Allergy Treatment Market: Segmentation

Global allergy treatment market is further segmented into following types:

• By Allergy Type
• Eye allergy
• Rhinitis
• Asthma
• Skin allergy
• Other allergy
• By Allergy Treatment Type
• Anti-allergy medicine
• Antihistamines
• Corticosteroids
• Decongestants
• Mast cell stabilizers
• Other medicines (Leukotriene, Calcineurin, Cromoglicate, Anti-IgE)
• Immunotherapy

Global allergy treatment market is further segmented into End User

• Hospital
• Clinics
• Medical store
• Home use
• Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Each year traumatic brain injuries (TBI) contribute a substantial number of cases worldwide. TBI can be defined as an injury to the brain resulting from externally inflicted trauma resulting in damage to the brain cells and blood vessels. The signs and symptoms of TBI may appear soon after the head trauma or may sometimes take several days to weeks to appear.

Gain complete access to the report @
https://www.futuremarketinsights.com/reports/traumatic-brain-Injuries-treatment-market

TBI can be categorized as mild, moderate and severe brain injury. In case of a mild injury a patient experiences a brief concussion and in rare situations may lead to lasting functional brain changes. However, the risk of developing severe and permanent brain damage increases with the extent and severity of the traumatic brain injury and the level of unconsciousness.

Depending up on the location of the injury,  TBI can lead to dementia along with memory, lack of concentration, problems related with speech and eating, lack of coordination and walking problems are often associated with moderate to severe brain injuries. As estimated by Center for Diseases Control and Prevention (CDC) every day 138 people in the U.S. die from TBI.

According to the CDC 2010 estimates in the U.S. approximately 2.5 million emergency department visits and hospitalization were associated with TBI cases (either alone or in combination with other injuries).  Falls are leading cause of hospitalization in patients with TBI followed by accidents including motor, vehicle traffic injuries.

Mild traumatic brain injuries do not require treatment other than over the counter pain relievers and the patient with mild traumatic injury need not to be monitored in hospital.  However for treatment of severe TBI several medications indicated includes several diuretics, anti- seizure drugs, comma inducing drugs etc.

However, in case of severe TBI surgery and rehabilitation is required. The traumatic brain injuries treatment market is expected to witness higher growth over the forecast period owing to introduction of several new therapies. Increasing number of manufacturers are developing new medications for the treatment of TBI and large number of clinical trials are conducted in order to better understand the etiology of the condition.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2678

Traumatic Brain Injuries Treatment Market: Drivers & Restraints

Extensive R&D by U.S. Food and Drug Administration (FDA) scientists in order to study various biomarkers of brain imaging, bio fluid and physical indicators such as eye tracking and electroencephalography holds immense potential as diagnostic techniques for detection of TBI. This is expected to change the treatment pattern of TBI in patients with severe brain injuries.

Apart from this a large number of clinical trials are conducted worldwide in order to develop effective therapies for TBI have proven to be opportunistic for the market growth of TBI treatment in the near future.

Furthermore rising incidence of falls cases along with accidental cases are expected to be the leading accelerating factors for market growth of TBI treatment market globally. The expected entry of some molecular targeted therapies such as BHR-100, a progesterone drug being developed by BHR Pharma, LLC,  rhuEpo, a recombinant human erythropoietin are expected to brace the TBI treatment market growth over the forecast period.

However, factors such as low societal awareness, delayed diagnosis and low government funding in TBI treatment research are expected to hamper the TBI treatment market growth in the future.

Traumatic Brain Injuries Treatment Market: Overview

The traumatic brain injury treatment market is expected to increase at an alarming rate among children’s and adults over the forecast period. In children’s, few outcomes of TBI may not be encountered at an initial stage of but can emerge in later developmental stages of his/her life which may lead to chronic behavior problems and  social isolation.

Better understanding of the injury mechanisms and its effect on sub-populations is required in order to manage the TBI. Growing number of falling cases and accidental cases worldwide are expected to drive revenue growth of TBI treatment in the near future.

Traumatic Brain Injuries Treatment Market: Region-wise Outlook

On the basis of region presence, traumatic brain injuries treatment market is segmented into seven key regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa. The incidence of TBI is higher in regions such as Asia Pacific, North America and Western Europe.

TBI is the major cause of mortality accounting for 30% of all death related injuries in the U.S. Presence of several pipeline therapies in treatment of TBI is expected to be the biggest driver in global TBI treatment market. Cognosci, a privately held U.S. start-up is developing a novel therapeutic compound, COG1410, for the treatment of TBI which is expected to launch in the coming years.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2678

Traumatic Brain Injuries Treatment Market: Key Players

Some of the key market players in the traumatic brain injuries treatment market are, Zimmer Biomet, Neuren Pharmaceuticals Ltd., Oxygen Biotherapeutics Inc, TEVA Pharmaceutical Industries Ltd., Ischemic,  Grace Laboratories LLC. Several key players developing therapeutics for TBI treatment include, Cognosci, Medicortex, Amarantus BioScience Holdings, Aldagen, NeuroScience Pharmaceuticals and Targacept.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-2678

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Diabetes has evolved as one of the primary healthcare epidemic characterized by high sugar levels and principle cause of mortality worldwide.  In 2014, World Health Organization (WHO) estimated 8.5% of adults living with diabetes.  A diabetic person cannot either synthesize enough insulin (type 1 diabetes) or either does not make enough insulin or cannot effectively use the insulin produced by the body (type 2 diabetes).

Another type of diabetes that occur in women during her pregnancy is gestational diabetes. However, gestational diabetes is usually resolved after delivery but can precede towards type 2 diabetes later in a women’s life.  Most of the continuous glucose monitoring devices are invasive and involves use of needles leading to increased chance of infection. Furthermore, the invasive glucose monitoring device is considered to be discrete glucose measurement system which cannot be practically used for continuous monitoring of blood glucose.

Certain evidences of hyperglycemia between measurements are however not recorded thus resulting in false or no representation of the blood glucose pattern.  Noninvasive monitoring of glucose levels eliminates the need of painful pricking with increased risk of infection, and amount of damage caused to the finger tissue.

Therefore, non-invasive continuous glucose monitoring devices are being widely investigated and studied over the past few years for their ability to monitor glucose continuously under highly controlled (e.g. in-clinic) conditions. Various techniques that involves measurement of blood glucose levels non-invasively includes, Near Infrared Spectroscopy (NIRS), Mid -Infrared Spectroscopy (Mid-IRS), Raman Spectroscopy, Photo-acoustic Spectroscopy (PA), Optical Coherence Tomography (OCT) and many more.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2613

Non- Invasive Blood Glucose Monitoring Devices Market: Drivers & Restraints

Rising prevalence of diabetes globally is expected to result in greater use of noninvasive blood glucose monitoring devices among the prevalent population. Owing to the several disadvantages imposed by the use of invasive blood glucose monitors and growing need to develop noninvasive glucose monitoring diagnostic techniques, the market for non- invasive blood glucose monitoring devices is expected to rise at a greater pace during the forecast period.

For instance, in June 2015, researchers in U.K. developed blood glucose device that utilizes low-powered lasers in order to measure the blood glucose levels on the skin surface. Also a bench-top version of the system is currently in clinical trials studies which might land in the market over the next few years.

This includes, a finger-touch device similar to a computer mouse and a wearable version for continuous blood glucose monitoring. In addition, increasing efforts by several startup manufacturers, for example, Prediktor Medical- a Norway based manufacturer is developing a wearable device for estimation of blood glucose levels based on the combination of several principles determining the noninvasive glucose monitoring including, advanced multivariate analysis and dynamic models for insulin or glucose interaction.

The device is expected to be in the form of a watch or bracelet communicating with the mobile phone or a tablet for data presentation.  This would enable patient’s monitor their glucose levels continuously without the need for an implant. Currently available blood glucose measuring devices lacks specificity and sensitivity due to the substantial physical and chemical interference.

Non-invasive glucose monitoring devices use multivariate regression analyses converting optical signal to glucose concentration. Hence the device should be designed in such a way that it leads to accurate detection of blood glucose levels imperative for optimum therapy and disease management.

Non- Invasive Blood Glucose Monitoring Devices Market: Overview

Rising prevalence of diabetes worldwide imposes significant economic consequences on the individual’s life. Currently, there are 350 million people worldwide estimated to live with diabetes. Thus continuous monitoring of blood glucose levels is essential in order to manage the ever increasing prevalent population living with diabetes currently.

For this reason manufacturers are focusing on developing diagnostic techniques that are highly reliable and monitors individual’s blood glucose levels with greater accuracy with the capability to improve glycemic control and patient wellbeing.

By integration of sensing elements, electronics along with a reliable power source in a single unit, noninvasive blood glucose monitors are offering immense opportunity for all the device manufacturers along with patients and various healthcare providers across the world. Accelerated regulatory approvals of blood glucose monitors is one of the another important factor leading to increased revenues of noninvasive blood glucose devices over the forecast period.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2613

Non- Invasive Blood Glucose Monitoring Devices Market: Region-wise Outlook

On the basis of region presence, Non- Invasive Blood Glucose Monitoring Devices market is segmented into seven key regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa.

Growing number of diabetic population in U.S. is the leading factor contributing towards higher adoption of noninvasive blood glucose monitoring systems. Center of Diseases Control and Prevention estimated 29.1 million of U.S. population with diabetes in the U.S. The data also estimated adult population with diabetes are at 50% higher risk of death.

Furthermore, growing need of continuous non-invasive method of blood glucose diagnosis among patients is expected to create higher demand for noninvasive blood glucose monitoring systems worldwide. The incidence of diabetes is higher in regions such as Asia Pacific, North America and Western Europe. Presence of several pipeline blood glucose monitoring systems and their expected launch is expected to drive the market for noninvasive blood glucose devices over the forecast period.

Non- Invasive Blood Glucose Monitoring Devices Market: Key Players

Some of the key market players in the non- invasive blood glucose monitoring devices market are, Abbott, Animas Technologies, Bayer Healthcare, Cercacor, Pendragon Medical, OrSense, and Bayer Healthcare.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2613

Non- Invasive Blood Glucose Monitoring Devices Market: Segmentation

Non- invasive blood glucose monitoring devices marketis segmented by technology, modality end user and geography:

By Technology

• MIR/NIR (Mid/Near Infrared Spectroscopy)
• Raman Spectroscopy
• Occlusion Spectroscopy
• Optical Coherence Tomography
• Thermal Emission Spectroscopy
• Photoacoustic Spectroscopy
• Impedance/Dielectric Spectroscopy
• Electromagnetic
• Polarimetry
• Fluorescence

By Modality

• Wearable Blood Glucose Monitoring Systems
• Non-wearable /Table top Blood Glucose Monitoring Systems

By End User

• Hospitals
• Home Care Settings
• Clinics
• December 2022
• REP-GB-2613
• Upcoming
• Healthcare

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs